BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Adipose tissue
,
Holistic medicine
,
Aspirin
,
rs2230926
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
exoribonucleases
Summary
General Info
Curated Studies
Most Correlated Studies
Glioblastoma microvesicles transport RNA and proteins
Stromal cell gene expression in response to treatment with tumor cell-derived exosomes
IFNg regulated gene expression in macrophages induced by exosomes isolated from Mtb-infected cells
Kidney embryonic 273 cells overexpressing exoribonuclease DIS3L2 D391N mutant
Embryonic kidney HEK293 cells overexpressing mutant or wildtype DIS3L2
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence po…
Arabidopsis mRNA decay landscape shaped by XRN 5'-3' exoribonucleases.
Identification of a novel deFADding activity in human, yeast and bacterial 5' to 3' exoribonucleases…
Defining the impact of exoribonucleases in the shift between exponential and stationary phases.
An RNA-seq based comparative approach reveals the transcriptome-wide interplay between 3'-to-5' exoR…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Remdesivir in COVID-19 Lahore General Hospital
"Efesovir" (FS-1) for COVID-19, Phase 2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ